Rare lung diseases

We're improving diagnosis and developing new treatments for rare lung diseases like primary ciliary dyskinesia, cystic fibrosis and idiopathic pulmonary fibrosis.


jane-lucas-175x175

Key investigator: Prof Jane Lucas

Prof Jane Lucas leads our research into rare lung diseases, to improve diagnosis, enable better disease management and develop new treatments.

Read full profile

 


Primary ciliary dyskinesia

Professor Jane Lucas

Primary ciliary dyskinesia (PCD) hinders the clearance of mucus, bacteria and debris from the lungs, increasing chances of infection. We conduct long-term research into how PCD progresses in both children and adults, and improving PCD diagnosis and treatment. 

Read more

Cystic fibrosis

Dr Mary Carroll

Our focus is on understanding and improving antibiotic treatment of lung infections in cystic fibrosis, and the psychological impact the condition has on patients and their caregivers.

Read more

Idiopathic pulmonary fibrosis

Prof Luca Richeldi

Idiopathic pulmonary fibrosis (IPF) is an incurable lung disease that results in death within a few years of diagnosis. We’re developing new patient-specific treatments and methods of diagnosis for IPF.

Read more

Hospital links 

University links